Scientific opinion on the renewal of the authorisation of Scansmoke SEF7525 (SF-004) as a smoke flavouring Primary Product.

SF‐004 Scansmoke SEF7525 benzofuran genotoxicity smoke flavouring Primary Product styrene

Journal

EFSA journal. European Food Safety Authority
ISSN: 1831-4732
Titre abrégé: EFSA J
Pays: United States
ID NLM: 101642076

Informations de publication

Date de publication:
Nov 2023
Historique:
medline: 29 11 2023
pubmed: 29 11 2023
entrez: 29 11 2023
Statut: epublish

Résumé

The EFSA Panel on Food Additives and Flavourings (FAF) was requested to evaluate the safety of the smoke flavouring Primary Product Scansmoke SEF7525 (SF-004), for which a renewal application was submitted in accordance with Article 12(1) of Regulation (EC) No 2065/2003. This opinion refers to the assessment of data submitted on chemical characterisation, dietary exposure and genotoxicity of the Primary Product. Scansmoke SEF7525 is obtained from a tar produced from a mixture of red oak, white oak, maple, beech and hickory. Based on the compositional data, the Panel noted that the identified and quantified proportion of the solvent-free fraction amounts to 32.6 weight (wt)%, thus the applied method does not meet the legal quality criterion that at least 50% of the solvent-free fraction shall be identified and quantified. At the maximum proposed use levels, dietary exposure estimates calculated with Food Additive Intake Model (FAIM) ranged from 0.6 to 3.8 mg/kg body weight (bw) per day at the mean and from 1.1 to 10.1 mg/kg bw per day at the 95th percentile. Based on the available information on genotoxicity on 44 identified components, the Panel concluded that two substances in the Primary Product, styrene and benzofuran, raise a potential concern for genotoxicity. In addition, a potential concern for genotoxicity was identified for the unidentified part of the mixture. Considering that the exposure estimates for styrene and benzofuran are above the threshold of toxicological concern (TTC) value of 0.0025 kg/kg bw per day for DNA-reactive mutagens and/or carcinogens and since further data are needed to clarify their potential genotoxicity, the Panel concluded that the potential safety concern for genotoxicity of the Primary Product cannot be ruled out.

Identifiants

pubmed: 38027432
doi: 10.2903/j.efsa.2023.8366
pii: EFS28366
pmc: PMC10652693
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e08366

Informations de copyright

© 2023 European Food Safety Authority. EFSA Journal published by Wiley‐VCH GmbH on behalf of European Food Safety Authority.

Références

EFSA J. 2021 Mar 02;19(3):e06435
pubmed: 33717353
Mutat Res. 1997 Apr 24;390(1-2):51-7
pubmed: 9150752
Toxicol Appl Pharmacol. 1999 Dec 1;161(2):153-9
pubmed: 10581209
EFSA J. 2017 Dec 18;15(12):e05113
pubmed: 32625393
Appl Biochem Biotechnol. 2000 Spring;84-86:153-62
pubmed: 10849786
EFSA J. 2018 Dec 18;17(1):e05519
pubmed: 32626066
Toxicology. 2004 Nov 15;204(2-3):187-95
pubmed: 15388244
Carcinogenesis. 1998 Jan;19(1):117-24
pubmed: 9472702
EFSA J. 2021 Aug 05;19(8):e06770
pubmed: 34386097
Regul Toxicol Pharmacol. 1997 Feb;25(1):1-5
pubmed: 9056496
Natl Toxicol Program Tech Rep Ser. 1989 Oct;370:1-189
pubmed: 12692651
EFSA J. 2020 Oct 14;18(10):e06247
pubmed: 33133270
Mutagenesis. 2010 Nov;25(6):539-53
pubmed: 20720197
EFSA J. 2021 Aug 03;19(8):e06769
pubmed: 34377191

Auteurs

Classifications MeSH